ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial
Maria Petracca, Mario Quarantelli, Marcello Moccia, Giovanni Vacca, Barbara Satelliti, Gianluigi D'Ambrosio, Antonio Carotenuto, Monica Ragucci, Francesco Assogna, Antonio Capacchione, Roberta Lanzillo, Vincenzo Brescia Morra
Topics & Concepts
TolerabilityMedicineCurcuminMultiple sclerosisPlaceboInternal medicineClinical endpointGastroenterologyClinical trialAdverse effectPharmacologyPathologyImmunologyAlternative medicineCurcumin's Biomedical ApplicationsMultiple Sclerosis Research StudiesMicroRNA in disease regulation